The Rules of Investing Life changing technology meets a structural growth industry
5 snips
Jul 18, 2025 Jacob Celermajer, founder of Cordis Asset Management and creator of Australia’s only pure play medtech fund, dives into the transformative world of medical technology. He discusses how innovation in healthcare rivals that of tech giants. Key topics include the promising investment landscape shaped by an aging population, the crucial role of medical advisory panels, and revolutionary treatments like mechanical thrombectomy that enhance patient outcomes. Celermajer offers valuable investing insights while navigating the unique challenges of the medtech sector.
AI Snips
Chapters
Transcript
Episode notes
Barriers Create MedTech Oligopolies
- MedTech markets typically have oligopolies due to high capital, regulatory, and IP barriers.
- These barriers discourage multiple competitors, protecting incumbents and enabling profitability without destructive price wars.
Use Volatility to Your Advantage
- Embrace volatility in medtech investing as an opportunity rather than a risk.
- Use short-term share price movements to buy quality companies at discounts for the long term.
Patents and Barriers Shield MedTech
- Regulatory and capital barriers stabilize medtech markets, reducing uncertainty for investors.
- Unlike pharma, MedTech can refresh patents continuously through product iterations, creating 'patents in perpetuity.'